2,3)
Exosomes are small (30-100 nm) membrane vesicles of endocytic origin that are released into the extracellular environment on fusion of multivesicular bodies with the plasma membrane. [4] [5] [6] During this process, certain cytosolic proteins are incorporated into the invaginating membranes, engulfed and enclosed in these vesicles, thereby maintaining the same topological orientation as at the plasma membrane. 7) It has been recognized that exosomes are involved in a novel mechanism of protein release. Exosome production has been observed in a variety of cell types in vitro, including reticulocytes, 8) cytotoxic T lymphocytes, 9) B lymphocytes, 10) dendritic cells, 11) and neoplastic intestinal epithelial cells. 12) Recent studies have reported that such vesicles are present in some physiological fluids, such as bronchoalveolar lavage 13) and urine. 14) More recently, it has been demonstrated that exosomes are released into saliva. 15, 16) While the biological functions of exosomes are still unclear, they can mediate expulsion of obsolete membrane constituents, communication between cells, facilitating processes such as antigen presentation and in trans signaling to neighboring cells. Recently, it was reported that exosomes contain both mRNA and microRNA (miRNA), which can be transferred to another cell, and be functional in that new environment. 17) There is growing interest in using whole saliva as a diagnostic fluid because of the relatively simple and non-invasive collection procedures used to harvest it. Recent studies show that exosomes are attractive biomarker candidates for diseases such as cancer. [18] [19] [20] In a previous study, we have isolated exosomes from human whole saliva through gel-filtration, and found that dipeptidyl peptidase IV (DPP IV), actin, polymeric immunoglobulin receptor (pIgR), immunoglobulin A (IgA) and galectin-3 were associated with exosomes. 15) However, detailed analysis of the protein composition was not performed. In addition, exosomes isolated from human whole saliva were heterogeneous in size. It prompted us to study whether they are simple mixtures of different sizes of vesicles that have the same characteristics, or a mixture of vesicles of different characteristics. In the present study, we have isolated two types of exosomes according to size from human whole saliva and performed proteomic analysis of the isolated exosomes.
MATERIALS AND METHODS

Materials
Gly-Pro-4-methyl-coumaryl-7-amide (GlyPro-MCA) was from Peptide Institute Inc. (Osaka, Japan). Sephacryl S-500 HR, Immobiline DryStrip gel and Pharmalyte were purchased from GE Healthcare U.K. Ltd. (Buckinghamshire, U.K.). a-Cyano-4-hydroxycinnamic acid (4-CHCA) was purchased from Shimadzu GLC (Tokyo, Japan). CXCL11 and CXCL12 were from R&D Systems, Inc. (Minnesota, U.S.A.). All other reagents were of the highest quality available. DPP IV inhibitor ER319711-15 was kindly provided from Eisai Co., Ltd. (Ibaraki, Japan).
Gel Filtration of Human Whole Saliva Whole saliva exosomes were purified as previously described with a slight modification. 15) Briefly, human whole saliva was collected from a single healthy female volunteer (37 years old) in our laboratory with informed consent. A volume of 35 ml of whole saliva was added to an equal volume of Tris-buffered saline (20 mM Tris-HCl, pH 7.4 and 150 mM NaCl). Then, the sample was centrifuged at 10000ϫg at room temperature for 5 min to precipitate bacteria and food debris. The supernatant was filtered through a 5.0 mm cellulose acetate filter and the filtrate was concentrated to approximately 1 ml using an Amicon Ultra-15 centrifugal filter device (Millipore Corporation, Massachusetts, U.S.A.) with a 100-kDa exclusion. The concentrated filtrate was subjected to gel-filtration on a Sephacryl S-500 column (1.5ϫ50 cm) equilibrated with Trisbuffered saline. Void fractions (Fr. I) and the following fractions displaying DPP IV activity (Fr. II) were collected, and concentrated approximately 100 fold using a Amicon Ultra-4 with a 100-kDa exclusion. These concentrated solutions were used for further characterization.
DPP IV Activity Assay DPP IV activity was assayed as previously described. 15) In brief, the assay mixture contained 50 ml of 0.4 mM Gly-Pro-MCA, 100 ml of 100 mM Tris-HCl buffer (pH 8.5) and 50 ml of enzyme solution. After incubation for 20 min at 37°C, 2.8 ml of 1 M sodium acetate (pH 4.2) was added to terminate the reaction. Fluorescence intensity of liberated 7-amino-4-methyl-coumarin was measured at 460 nm with excitation at 380 nm. Protein concentration was determined using the BCA reagent (Pierce, U.S.A.).
Electron Microscopy Immunoelectron microscopy was performed as described previously.
15) The concentrated solution of exosome fractions prepared as described above was mixed 1 : 1 with 4% paraformaldehyde in phosphate-buffer (pH 7.2) and then applied to 200-mesh Formvar-carboncoated nickel grids. The grid was stained with 2% uranyl acetate, pH 7, and embedded with 2% methylcellulose/0.4% uranyl acetate, pH 4. After drying, the grids were examined with a transmission electron microscope (TEM-1010; JEOL, Tokyo, Japan).
Western Blot Analysis The proteins in the exosome fractions prepared as described above were separated on a SuperSep HG, 5-20% gradient gel (Wako Pure Chemical Industries, Ltd., Osaka, Japan) and transferred to a polyvinylidene difluoride (PVDF) membrane using a semidry transfer method (Bio-Rad Laboratories, Inc., California, U.S.A.). Nonspecific binding sites were blocked by incubating the membrane in 100 mM Tris-HCl (pH 7.4)/150 mM NaCl, containing 3% skim milk and 1% Tween 20. Blots were incubated overnight at 4°C with goat anti-Alix polyclonal antibody (Santa Cruz Biotechnology, Inc., California, U.S.A.), goat anti-tumor susceptibility gene 101 (Tsg101) polyclonal antibody (Santa Cruz Biotechnology, Inc.), mouse anti-heat shock protein 70 (Hsp70) monoclonal antibody (Bioscience Inc., Victoria, Canada), rabbit anti-CD63 antigen polyclonal antibody (Santa Cruz Biotechnology, Inc.), mouse anti-actin monoclonal antibody (Chemicon, Temecula, California, U.S.A.), rabbit anti-galectin-3 polyclonal antibody (Santa Cruz Biotechnology, Inc.), goat anti-DPP IV antibody (R&D Systems, Inc., Minnesota, U.S.A.), goat anti-GW182 polyclonal antibody (Santa Cruz Biotechnology, Inc.), goat anti-Ig alpha chain antibody (Bethyl Laboratories, Inc., Texas, U.S.A.), goat anti-Ig kappa chain antibody (Invitrogen Corporation), goat anti-Ig lambda chain antibody (Invitrogen Corporation), goat anti-Ig J chain antibody (Santa Cruz Biotechnology, Inc.), goat anti-Ig gamma chain antibody (Invitrogen Corporation), or goat anti-Ig mu chain antibody (Invitrogen Corporation). These antibodies were detected using horse-radish peroxidase (HRP)-conjugated secondary antibodies and visualized using enhanced chemiluminescence (ECL or ECL Plus, GE Healthcare Bio-Science Corp., U.S.A.).
Two Dimensional Polyacrylamide Gel Electrophoresis (2-D PAGE) Protein extraction and 2-D PAGE were performed as previously reported 21) (see also http://proteome. tmig.or.jp/2D/2DE_method.html), with slight modifications. Briefly, the concentrated fractions prepared as described above were supplemented with three volumes of the extraction buffer (5 M urea, 2 M thiourea, 0.2% CHAPS, 2% sulfobetaine10, 65 mM DL-dithiothreltol, and 2% Pharmalyte 3-10). The fractions were subsequently disrupted by sonication (20 pulses), and debris was removed by centrifugation (10000ϫg, 5 min). The supernatants were concentrated to approximately 50 ml using a Microcon Ultracel YM-3 centrifugal filter device (Millipore Corporation, Massachusetts, U.S.A.) with a 30-kDa exclusion. The protein in each of the 40 ml aliquots of the extract (ca. 40-80 mg protein) was loaded onto reswollen gel strips with immobilized pH gradient (IPG) (pH 3-10, 3-5.6 and 7-11, 18 cm long), and then isoelectronic focusing (IEF) was performed using a CoolPhoreStar IPG-IEF Type P (Anatech, Tokyo, Japan). After completion of IEF, the strips were sodium dodecyl sulfate (SDS) equilibrated, reduced and alkylated with dithiothreitol (DTT) and iodoacetamide. Next, SDS-PAGE (7.5% acrylamide concentration) was performed using a CoolPhoreStar SDS-PAGE Dual-200 (Anatech). After separation on 2-D PAGE, the protein spots on the gel were fixed in 50% methanol and 10% acetic acid for 30 min and stained with SYPRO Ruby protein gel stain (Invitrogen Corporation) for detection of proteins. The gel images were obtained by scanning with a Molecular Imager FX Pro (Bio-Rad Laboratories, California, U.S.A.). Quantitative analysis of proteins on gel images was performed by JustTLC software (Sweday, Lund, Sweden).
In-Gel Protein Digestion and Mass Spectrometry Ingel digestion on selected gel spots of 2-D PAGE was also performed according to the protocol listed on the URL described above. Each protein spot was subsequently excised using a FluoroPhoreStar 3000 (Anatech, Tokyo, Japan). A piece of gel from each protein spot was decolored, and decomposed into several peptides by the addition of a digestion reagent containing 10 mg/ml sequencing-grade modified trypsin (Promega, Wisconsin, U.S.A.), 50 mM ammonium bicarbonate, and 30% acetonitrile (ACN) and incubated at 30°C, overnight. The peptides produced from in-gel digestion were directly mixed with matrix solution (5 mg/ml CHCA in 50% ACN/0.1% trifluoroacetic acid (TFA)) and applied to the target (Sample Plate 384; Shimadzu Biotech, Kyoto, Japan). The samples were analyzed by matrix-assisted laser desorption/ionization time-of flight mass spectrometry (MALDI-TOF-MS) using an Axima CFRplus instrument (SHIMADZU, Corp., Kyoto, Japan) in positive linear mode with 20 kV acceleration voltage. Proteins were identified with the Mascot search engine (Matrix Science, London, U.K.; see the URL, http://www.matrixscience.com/) searching algorithms by using the Swiss-Prot protein database or NCBInr database. Mascot search parameters are shown as follows: type of search, peptide mass fingerprinting (PMF); enzyme, trypsin; max missed cleavage, 2; fixed modifications, carbamidomethyl (C); variable modifications, oxidation (M); peptide mass tolerance, Ϯ0.4 Da; mass values, MH ϩ ; monoisotopic. When the same protein was detected from at least two gels, the Mascot search result was considered to be correct. Alternatively, digested peptides were analyzed by LC/MS/MS. LC/MS/MS Analysis The tryptic digests were loaded onto a L-column ODS trapping column (Chemicals Evaluation and Research Institute, Tokyo, Japan). After a wash with 15 ml of 0.1% TFA, the trapping column was switched into line with the column. HPLC was performed on a Paradigm MS 4 (Michrome Biosources, Auburn, CA, U.S.A.) equipped with a C18 L-column (0.3ϫ150 mm) at a flow rate 0.5 ml/min. The eluents consisted of water containing 2% (v/v) ACN and 0.1% (v/v) formic acid (pump A) and 90% ACN and 0.1% formic acid (pump B). Samples were eluted with 5% of B for 2 min followed by a linear gradient from 5 to 80% of pump B in 20 min.
Mass spectrometric analyses were performed using a quadrupole time-of-flight (Q-TOF) mass spectrometer QSTAR elite (Applied Biosystems, California, U.S.A.) equipped with a nano-electrospray ion source. The mass spectrometer was operated in the positive ion mode. The nanospray voltage was set at 2400 V. Mass spectra were acquired at m/z 400-2100 for MS analysis and at m/z 100-2100 for MS/MS analysis. After every regular MS acquisition, two MS/MS acquisitions against the two top multiply charged molecular ions were performed (data-dependent acquisition). The precursor ions with the same m/z as acquired previously were excluded for 60 s. The collision energy was varied depending on the size and charge of the molecular ion. All peaks were resolved monoisotopically. Tandem MS/MS data from LC/MS/MS runs were submitted to the Mascot search engine (Matrix Science, London, U.K.; see the URL, http://www.matrixscience.com/) searching algorithms by using the Swiss-Prot protein database or NCBInr database. One missed cleavage was allowed, and tolerances of 2.0 and 0.8 u mass were used for precursor and product ions, respectively. When the same protein was detected from at least two gels, the Mascot search result was considered to be correct.
Shotgun Analysis Shotgun analysis of the each exosome was performed as previously reported 22) with slight modifications. Proteins (100 mg) of the concentrated solutions from Fr. I or Fr. II were dissolved in 50 ml of 0.5 M Tris-HCl buffer (pH 8.6) that contained 8 M guanidine hydrochloride and 5 mM ethylenediaminetetraacetic acid (EDTA). After the addition of 2 ml of 1 M DTT, the mixture was incubated for 30 min at 65°C. Then, 4.8 ml of 1 M sodium iodoacetate was added, and the resulting mixture was incubated for 40 min at room temperature in the dark. The reaction mixture was applied to a PD-10 column (GE Healthcare U.K. Ltd., Buckinghamshire, U.K.) to remove the reagents, and the eluate was lyophilized. The reduced and carboxymethylated samples were redissolved in 100 ml of 0.1 M Tris-HCl buffer (pH 8.0). An aliquot of 2 ml of 1 mg/ml sequencing-grade modified trypsin was added, and then the mixtures were incubated for 16 h at 37°C. The enzyme digestion was stopped by boiling for 10 min and stored at Ϫ20°C before analysis. Tryptic digests of the samples were analyzed by LC/MS/MS as described above except that a gradient condition of 5 to 80% of solvent from pump B over 60 min was employed. The MS/MS spectra were searched against the Swiss-Prot protein database using the Paragon algorithm in Protein Pilot software 2.0 (Applied Biosystems, California, U.S.A.). The experiment was repeated at least four times. Protein with a probability of Ͼ0.99 were reported.
Cleavage of Chemokines by Exosome CXCL11 or CXCL12 (at a final concentration of 10 mM for each peptide) were incubated with exosome II (1 mg of total protein) from human saliva for 20 or 120 min at 37°C in a total volume of 0.2 ml of 100 mM Tris-HCl buffer (pH 7.4). The reactions were quenched by adding TFA to a final concentration of 0.1%. Using ZipTip C18 tips (Millipore, Bedford, MA, U.S.A.), a 20 ml aliquot of the digested mixture was desalted, concentrated and then eluted with 1 ml of matrix solution (5 mg/ml CHCA in 50% ACN/0.1% TFA) and spotted onto a sample plate. Samples were analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) on an Axima CFRplus instrument in positive linear mode with 20 kV acceleration voltage.
RESULTS
Isolation and Characterization of Exosomes from
Whole Saliva Salivary protein isoforms, which are linked to gene duplication, differential mRNA splicing, and posttranslational modifications, such as proteolysis, phosphorylation and glycosylation, are expected to vary across the population. 23) Thus, repeated collection of salivary samples were obtained and pooled from only one donor. In a previous study, we have isolated human saliva exosome in the void fractions using Sephacryl S-300 gel column chromatography. In the present study, we fractionated human whole saliva using gel-filtration on a Sephacryl S-500 column with a mean exclusion size of 200 nm, which is suitable for fractionating macromolecules (Fig. 1) . Two small protein peaks were observed in fraction number 28 and 38. The peak of DPP IV activity matched fraction number 38, so we collected fraction number 25-30 and 34-45 as pooled fraction Fr. I and Fr. II, respectively. Fr. I corresponded to the void fraction. Then, Fr. I and Fr. II were concentrated and observed by electron microscopy (Fig. 2) . Vesicles from Fr. I had a relatively large size and high electronic density. They were close to round-shape or slightly elongated. Size distribution of the vesicles varied from 30 to 250 nm with a mean diameter of 83.5 nm (SEϭ2.5 nm) (Fig. 3) . In contrast, vesicles from Fr. II had uniform size and shape similar to those of exosomes reported from other sources. 18) Size distribution of the vesicles varied 20 to 80 nm with a mean diameter of 40.5 nm (SEϭ0.4 nm) (Fig. 3) .
1-Dimensional (1-D) PAGE analysis revealed that the vesicular protein patterns of Fr. I and Fr. II were different from each other and from that of whole saliva (Fig. 4A ). Bands higher than approximately 75 kDa were enriched in both of the vesicles. Western blot analysis showed that both vesicles were positive for exosomal markers such as Alix, Tsg101, Hsp70 and CD63, suggesting that the both vesicles are exosomes (Fig. 4B) . We designated the vesicles from Fr. I and Fr. II as exosome I and exosome II, respectively. In a previous study, we have found DPP IV and galectin-3 to be present in exosomes from human whole saliva. 15) DPP IV was detected with much higher intensity in exosome II than in exosome I by western blot analysis, which was consistent with the result observed on gel-exclusion column chromatography on Sephacryl S-500 (Fig. 4B ). Galectin-3 was detected in both exosome I and exosome II. In addition, GW182, which is required for miRNA function, was detected in exosome II with higher intensity than in exosome I.
Identification of Proteins from Whole Saliva Exosomes
We performed proteomic analysis of exosome I and exosome II using 2-D PAGE from pH 3 to 10. To identify acidic and basic proteins, we also used 2-D PAGE with different pH ranges (pH 3-5.6, 7-11, data not shown). Figure 5 shows representative 2-D PAGE patterns using a focusing range of pH 3-10. To identify proteins in selected gel spots, a peptide mass fingerprinting method (PMF) was carried out using MALDI-TOF-MS. When identification by MALDI-TOF-MS was not successful, further attempts were made by peptide sequencing using LC/MS/MS. The proteins successfully identified are listed in Table 1 . A total of 47 and 51 proteins were identified from exosome I and exosome II, respectively, from 2-D PAGE gel spots. In both exosome I and exosome II, IgA (Ig alpha-1 chain, Ig alpha-2 chain, Ig lambda chain, Ig kappa chain, and Ig J chain) and pIgR were common major proteins. By quantitative analysis of 2-D PAGE images, Ig alpha chains and pIgR accounted for approximately 35% and 14% of total proteins in exosome I, and 20% and 9% in exosome II, respectively. Since immunoglobulins were detected from many spots in a broad area in 2-D PAGE, immunodetection was also used to identify the area containing each immunoglobulin such as Ig alpha-1 and alpha-2 chain, Ig mu chain, Ig gamma chain, Ig kappa chain, Ig lambda chain and Ig J chain (data not shown). Meanwhile, the 2-D PAGE of exosome I and exosome II showed different pat- 16 Vol. 34, No. 1
Fig. 2. Electron Microscopy of Exosome I (A) and Exosome II (B) from Human Whole Saliva
Scale barϭ200 nm. terns. For example, salivary proteins such as DPP IV (spot 3), carbonic anhydrase 6 (spot 30), short palate, lung and nasal epithelium carcinoma-associated protein 2 (parotid secretory protein) (spot 31), IgG Fc binding protein (spot 2), and cystatin family proteins (spot 43, 45, 46) , were distinctly present in exosome II (Fig. 5B) . In contrast, mucin-5B (spot 1) was present with much higher spot intensity in exosome I than in exosome II (Fig. 5A) .
To increase the proteome coverage obtained by 2-D PAGE analysis, we undertook shotgun proteomics analysis. Total proteins extracted from each exosome were digested with trypsin, and resultant peptides were subjected to LC/MS/MS analysis for protein identification. A total of 76 and 135 proteins were identified from exosome I and exosome II, respectively (Table 1) . Overall, 101 and 154 proteins were identified from exosome I and exosome II, respectively, by a combination of 2-D PAGE analysis, shotgun analysis and western blot analysis. Sixty-eight proteins were common between the two types of exosomes. With the information provided via the accession number, proteins identified in exosome I and exosome II could be grouped into categories of subcellular localization (Fig. 6) . The protein composition of exosome I was similar to that from exosome II. Approximately 40% of the proteins identified were secretory or extracellular proteins, while at least 50% of the protein could be associated with the cytoplasm, plasma membrane or nucleus.
Degradation of Chemokines by Exosome II DPP IV selectively removes the N-terminal dipeptides from peptides with proline or alanine in the penultimate position. Almost all of the DPP IV activity in whole saliva was present in exosome II (Fig. 1) . We next investigated whether the exosome II was active in the degradation of bioactive peptides such as chemokines. CXCL11 and CXCL12 are cleavable by DPP IV, and are known to be expressed in salivary glands. 24, 25) CXCL11 was cleaved only at the Pro2-Met3 position when incubated with exosome II (data not shown). No other peptide fragments were observed. This cleavage was completely inhibited by specific DPP IV inhibitor ER319711-15.
26) By contrast, CXCL12 was first cleaved at Pro2-Val3 and subsequently hydrolyzed at Leu5-Ser6 (Fig. 7) . When a specific DPP IV inhibitor was added, cleavage at Pro2-Val3 was inhibited, but CXCL12 was still cleaved at Leu4-Ser5.
DISCUSSION
In this study, human saliva exosomes were fractionated into at least two types of vesicles, exosome I and exosome II. They were different in size and protein composition. Size and shape (round-shape) of exosome II match those observed in exosomes from other sources. Exosome I was larger than exosome II, and had an electron-dense structure. Both vesicles had exosomal marker proteins such as Alix, Tsg 101, CD63 and Hsp70. Various proteins required for ESCRT (endosomal sorting complex required for transport) recruitment to endosomal membranes are associated with exosomes. 27, 28) Alix and Tsg101 are components related to the ESCRT sorting mechanism. Alix is necessary for the targeting of endosomes and has been demonstrated to interact with Tsg101 which is a component of ESCRT I complex. CD63 (LAMP3, lysosomal membrane associate glycoprotein-3) which belongs to the tetraspanin family and heat shock protein Hsp 70, are often found in exosomes. 1) Recently, it has been found that exosomes contain miRNA, small noncoding RNAs, which suppress the translation of target mRNAs. 17) More recently, it was shown that exosomes also contains GW182, a component of RNA-induced silence complex, which is required for miRNA function. 29) GW182 was detected in both exosome I and exosome II. Investigations to detect miRNA in exosome I and exosome II are in progress. Apoptotic vesicles and microvesicles represent heterogeneous populations of membrane vesicles, budding directly from the plasma membrane and carrying a number of nuclear, cytosolic, and endoplasmic reticulum-derived proteins. 28, 30) Sizes of those vesicles are much larger (100-1000 nm) than exosomes. Histones and integrins are enriched in apoptotic vesicles and microvesicles, 28, 31) respectively, whereas those proteins were absent in exosome I and exosome II. These results support that the two types of vesicles identified in this study are exo- Proteins were separated in the first dimension on a 18-cm IPG strip (pH 3-10) followed by 7.5% SDS-PAGE. Separated proteins were stained with SYPRO Ruby. Crosses indicate spots used for protein identification. Spot numbers refer to proteins listed in Table 1 . Identical proteins are shown by the surrounded area. somes. However, the morphology of exosome I was somewhat different from that of typical exosomes. Further characterization will be necessary to confirm that these vesicles are exosomes.
Exosomes are generated with transmembrane and peripheral membrane proteins incorporated into the invaginating membrane in the same topological orientation as at the plasma membrane, while cytosolic proteins are engulfed and enclosed into the vesicles. Exosome I and exosome II contain many plasma membrane proteins: single-pass transmembrane proteins such as type I membrane proteins-carcinoembryonic antigen-related cell adhesion molecule 1, and type II membrane protein-DPP IV and Golgi membrane protein 1; tetraspanins-CD63, CD81, and CD9; pentaspan membrane protein-Prominin-1 (CD133); six-pass membrane proteinaquaporin-5; seven-pass membrane protein-G-protein coupled receptor family C group 5 member C; GPI-anchored proteins-CD59, melanotransferrin, CD14 and complement decay-accelerating factor (CD55). These membrane proteins have often been identified in known exosomes. Integral plasma membrane proteins were 10-15% of identified proteins in exosome I and exosome II (Fig. 6 ). This ratio is simi- 20 Vol. 34, No. 1 a) The Mascot algorithm was used to identify the protein name and the accession number in Swiss-Prot. b) Protein annotation was obtained by using UniProtKB/SwissProt. c) Identification method: PMF, 2-D PAGE followed by MALDI-TOF-MS peptide fingerprint; LC, 2-D PAGE followed by peptide sequencing using LC/MS/MS; S, Shotgun analysis; W, western blot analysis. d) Exosome types and spot number in 2-D PAGE (Fig. 5 ) (in parentheses): I, exosome I; II, exosome II. lar to that (13%) in parotid gland exosome.
16) The relatively high proportion of plasma membrane proteins in the exosome is supported by the fact that the exosome is a membrane vesicle of endocytotic origin. 4) IgA and pIgR were major common components of exosome I and exosome II. Meanwhile, there were notable differences between them, even if there was any cross contamination due to limitations of the separation method. DPP IV, carbonic anhydrase 6, and cystatin family proteins are expressed more abundantly in exosome II. Moreover, exosome II contained more IgG Fc binding protein and galectin-3 binding protein than exosome I. In contrast, exosome I exclusively contained a number of proteins, including ezrin, moesin, radixin, Rab GDP dissociation inhibitor beta, alphaenolase, guanine nucleotide-binding protein Gi/Gs/Gt subunit beta-1 and annexins. In addition, mucin-5B was abundant in exosome I. Whereas alpha-amylase (about 20% in weight of salivary proteins) and proline-rich proteins (about 40% in weight of salivary proteins), both abundant protein components in whole saliva, 32) only a small amount or none of these proteins were detected in exosome I and exosome II. In contrast, carbonic anhydrase 6 and cystatin family proteins are also extracellularly secreted proteins that are minor components in whole salivary proteins, but distinct amounts of these proteins were detected in exosome II. It is likely that salivary proteins may be associated with each exosome in a specific way during exosome formation.
Human seminal fluid contains exosome-like vesicles called prostasomes. 33) Their size generally varies from 50 to 200 nm. Recently, Poliakov et al. described that the prostasome could be classified into at least three distinct structural types of vesicles, one of which was named "a dark vesicle" that had high electron density. 34) Its size ranged from 100 to 200 nm, and it was nearly round or slightly elongated. These features appear similar to those of exosome I. However, it remains to be elucidated whether exosome I is the same type of vesicle as a "dark vesicle." At present, the underlying mechanism for formation of prostasome heterogeneity is unclear. However, Poliakov et al. postulated that the structural heterogeneity of prostasomes may reflect their origin from several organs such as prostate, testes and epididymis. The structural heterogeneity of salivary exosomes might reflect the origin from several salivary glands. Whole saliva is composed mainly of salivas from the contralateral major (parotid, submandibular, sublingual) and minor salivary glands. Primary saliva secretion is elaborated by the acinar cells in the respective salivary gland and then it is modified as it passes through a series of progressively large ducts.
35) The Human Protein Atlas (http://www.proteinatlas.org/) shows that pIgR locates acinar cells and the ductal epithelial cells in human salivary glands, and that galectin-3 binding protein, which was detected in exosome I and exosome II, is located in the surface of the ductal epithelial cell. In addition, galectin-3 has been reported to be expressed in ductal epithelium cells in salivary glands. 36) DPP IV is expressed in ductal epithelium cells and acinar cells.
37) The distributions of these salivary gland proteins indicate the possible origin of exosome I and exosome II from ductal, acinar or both cell types. Sublingual secretion contains high amounts of mucin-5B, 38) suggesting that exosome I might be derived from at least the sublingual gland. In contrast, moesin, which was detected only in exosome I, has been reported to be present in B cell-derived exosomes. 39) Exosome I may be partially derived from B cells in salivary glands. Indeed, salivary glands are rich in B cells that produce IgA. Recently, exosomes were isolated from parotid saliva, and 491 proteins were identified by shotgun analysis using multidimensional protein identification mass spectrometry. 16) Many of the proteins were common to the proteins found in exosome I and exosome II, including exosomal markers (Alix, Tsg101, Hsp70, CD63), actin, DPP IV and galectin-3. Parotid gland exosome contains carbonic anhydrase 6, suggesting that exosome II may be derived at least in part from the parotid gland. In addition, a previous immunohistochemical study has demonstrated the cellular origins of carbonic anhydrase 6 in the parotid and submandibular glands of humans. 40) Exosome II may be derived from, at least in part, both of these salivary glands. Thus, it is considered that exosome I and exosome II are derived from several salivary glands and cell types. However, further study will be needed to clarify the origins of exosome I and exosome II.
Salivary glands express a variety of bioactive peptides such as neuropeptides, incretin and chemokines. 41, 42) In a previous study, we showed that exosomes from human whole saliva cleave substance P and glucose-dependent insulinotropic polypeptide (GIP). 15) CXCL11, CXCL12 (SDF-1), CXCL10, and CCL5 (RANTES) share the X-Pro motif at the N-terminus and are released from salivary epithelial cells. 24, 25, 43, 44) The present study revealed that exosome II was metabolically active in cleaving CXCL11 and CXCL12. Cleavage of CXCL11 was completely inhibited by DPP IV inhibitor, suggesting that DPP IV is responsible for its cleavage. Interestingly, CXCL12 was cleaved at Leu5-Ser6 even in the presence of a DPP IV-specific inhibitor, suggesting that exosome II contains another protease. Unfortunately, a candidate protease could not be found in the list of the proteins identified in the present study. Further research will be needed to elucidate a protease capable of cleaving CXCL12.
Regardless of their uncertain physiological role, exosomes have the potential to modulate the immune response through activation and perhaps also suppressing the immune system. 28) Exosome I and exosome II contained IgA at a high rate, suggesting that these exosomes might play a regulatory role in local immune defense in the oral cavity. Pathogens captured by IgA on exosome I and exosome II may be delivered to the lymphoid organs such as the tonsils and uptaken by dendritic cells. It is reported that exosomes are internalized efficiently by dendritic cells. 45) Dendritic cells are the most potent antigen-presenting cells that specialize in the initiation of immune responses by directing the activation and differentiation of naïve T lymphocytes. 46) Our preliminary experience shows that the antibody against DPP IV was produced successfully when exosome II was injected as an antigen without adjuvant intraperitoneally in mice. This antibody production was higher than that raised by a soluble recombinant DPP IV as an antigen. These results suggest that exosome II exhibits higher immunogenicity. In fact, it is reported that delivering antigens in vivo through exosomes is more immunogenic than the mere delivery of the soluble form in tumor models. 47) DPP IV, also known as CD26, functions not only to degrade biologically active peptides, but also to regulate the immune response. 48 ) DPP IV/CD26 influences proliferation in stimulated human T cells through binding to caveolin-1 on antigen-presenting cells (APC). 49, 50) As exosome II contains a characteristic amount of DPP IV, exosome II may have both antigen-delivering function but also direct APC stimulating function. The present study is the first exploration into the proteome of exosomes from human whole saliva, and results indicate that the proteome from the two types of exosome differs. Future studies are needed to characterize the two types of exosomes more in detail and clarify the biological significance of these exosomes in the oral cavity. Our proteomic analysis may provide a list of candidate proteins for future structural and functional studies.
